Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagonist Therapeutics

43.77
-0.5000-1.13%
Pre-market: 43.780.0100+0.02%09:09 EDT
Volume:840.13K
Turnover:36.91M
Market Cap:2.71B
PE:50.75
High:45.26
Open:44.44
Low:43.20
Close:44.27
Loading ...
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 11, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 02, 2020

Major Issues Report

8-K/A [Amend] - Current report
Sep 11, 2020

Major Issues Report

8-K - Current report
Aug 13, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 08, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 29, 2020

Major Issues Report

8-K - Current report
May 22, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 12, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Major Issues Report

8-K - Current report